Antibody production underpins biotech progress. Biointron explains traditional and recombinant methods that enable scalable, reliable antibody development.
Antibody diagnostics like ELISA and lateral flow assays are essential tools. Biointron showcases their role in reliable disease detection and rapid clinical decisions.
Antibody structure and dynamics drive therapeutic success. Biointron highlights how molecular insights improve stability, function, and performance of antibody drugs.
Antibody research depends on sensitivity. Biointron explores how antigen quality and experimental conditions affect results and guide better antibody development.
Infectious diseases like HIV and COVID-19 require novel therapies. Biointron shows how antibody drugs target pathogens to prevent infection and support recovery.
Discover how afucosylated antibodies enhance ADCC by increasing FcγRIIIa binding affinity, with clinical examples and applications in oncology and autoimmune disease therapy.
Autoimmune diseases demand precision therapy. Biointron explains how antibody drugs target RA, MS, and other conditions to reduce inflammation and improve outcomes.
Antibody therapeutics revolutionize oncology. Biointron highlights checkpoint inhibitors, targeted antibodies, and strategies advancing cancer treatment.
Muronomab (Orthoclone OKT3) made history as the first FDA-approved monoclonal antibody. Biointron reviews its impact on immunotherapy and antibody drug development.
scFvs combine compact design with strong binding. Biointron explores their history, therapeutic applications, and role in diagnostics and research innovation.
VHH antibodies have reshaped biotech. Biointron reviews their discovery, unique advantages, and applications driving innovation in diagnostics and therapeutic development.
Learn how transgenic animals are transforming antibody discovery by generating fully human antibodies for biomedical research, diagnostics, and drug development.
Antibodies defend health by neutralizing pathogens, aiding phagocytosis, and activating complement. Biointron explains these vital functions in immunity and therapy.
Analytical tools define antibody quality. Biointron applies SPR, BLI, and mass spectrometry to deliver precise characterization and support therapeutic success.
Explore the role of anti-idiotype antibodies and critical reagents in therapeutic antibody development, ensuring specificity, potency, and safety in drug testing.
You can also contact us on the Scientist and Science Exchange marketplaces.
